MSTN and oculopharyngeal muscular dystrophy: Treatment With Anti-myostatin Antibody Has Minimal Effect on Muscle Mass and Muscle Fiber Diameter, and Intranuclear Inclusion Density in 52-Week Old OPMD Mice